Showing 1 to 2 of 2 results


High Dropout Rate Among Weight Loss Drug Users
A new analysis reveals that 52 percent of over 77,000 people using anti-obesity drugs in Denmark stopped within a year, raising concerns about long-term adherence and highlighting socioeconomic disparities in access.
High Dropout Rate Among Weight Loss Drug Users
A new analysis reveals that 52 percent of over 77,000 people using anti-obesity drugs in Denmark stopped within a year, raising concerns about long-term adherence and highlighting socioeconomic disparities in access.
Progress
20% Bias Score

Weight Regain Follows GLP-1 Medication Discontinuation
A study in BMC Medicine reveals that patients stopping GLP-1 weight-loss drugs like Wegovy and Ozempic regain weight within two months, highlighting the chronic nature of obesity and need for ongoing management, despite continued healthy habits.

Weight Regain Follows GLP-1 Medication Discontinuation
A study in BMC Medicine reveals that patients stopping GLP-1 weight-loss drugs like Wegovy and Ozempic regain weight within two months, highlighting the chronic nature of obesity and need for ongoing management, despite continued healthy habits.
Progress
36% Bias Score
Showing 1 to 2 of 2 results